Myles Keck

Myles Keck is a Clinical Assistant Professor in the Department of Infectious Diseases at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy. His clinical practice focuses on antimicrobial stewardship and infectious diseases consultations. He completed his Pharm.D. at Lipscomb University (2016-2020), followed by a PGY-1 residency at Baptist Memorial Hospital – Memphis and a PGY-2 residency in Infectious Diseases at the University of Mississippi Medical Center.

His research interests span antimicrobial strategies, pharmacotherapy, and cannabinoid-quinone mechanisms in cancer. Notable work includes studies on HU-331 (a cannabidiol oxidation product) and copper-based compounds targeting DNA topoisomerases.

No scientific awards are explicitly listed, but he is a member of the Society of Infectious Diseases Pharmacists (SIDP). His professional activities include clinical rounds and stewardship initiatives, with publications in Journal of Cannabis Research and Chemical Research in Toxicology.